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DHHS (USA Department of Health and Human Services) Adult 
Antiretroviral Treatment Guidelines and Portuguese Governmental 
Guidelines were updated in 2012/2013. These recommend a non 
nucleoside reverse transcriptase inhibitors (NNRTI) as initial combined 
antiretroviral therapy and a ritonavir-boosted protease inhibitors (PI/r) as 
an alternative regimen which have an higher genetic barrier. Regimens 
based on thymidine analogues [Zidovudine AZT) are considered not 
recommended regimens based on tolerability and adverse reactions, 
however economic issues were taken into account in our hospital by 
choosing a protocol with AZT/lamivudine(3TC)/LPV/r(lopinavir/ritonavir). 
http://aidsinfo.nih.gov/guidelines 24/05/2013 
 Norma da DGS. nº 027/2012 de 27/12/2012 
It was conducted an observational retrospective study (medical records) 
including 72 HIV-positive naïve subjects aged over 18 years who started 
antiretroviral therapy from January to December 2011. We checked patient 
electronic clinical files during one year. First prescribed treatment, further 
treatment changes, virological and immunological status before and after 6 
months treatment were assessed. Treatments were classified as 
recommended, alternative or not recommended according to guidelines. 
Virological response was defined as undetectable viral load after 6 months 
of treatment.  
The mean age was 42 years old and 48 patients (66.7%) belonged to 
the male gender.  At enrolment, 9 patients (12.5%) didn’t have drug 
resistance test recorded in their clinical charts and 5 (7%) had mutated 
resistant virus strains. The mean CD4 count was 231 cells/µL and 
mean viral load was 323115 copies/mL.  Among the 72 patients, 21 
(29%), 14(19%) and 37(51%) started a recommended, alternative and 
not recommended treatment respectively.  None of the patients that 
received recommended regimen had changed the therapeutics or had 
virological failure. The most common prescribed regimen was 
LPV/r+3TC+AZT 59.7% (43 patients) and was not associated with 
higher mortality or poor compliance, with less 3000 Euros/patient/year, 
a potent virological efficacy (100%) with only 19% of adverse effects 
due to AZT(8 patients). Mean therapeutic compliance was 93%. 
Not adherence to guidelines doesn’t have a negative impact on virological and clinical outcomes. 
Given the severe budget restraints we had decided to maintain the existing protocol in our hospital.  
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Evaluate the percentage of patients treated according to the guidelines, 
assess the impact on mortality, virological and immunological response 
with both regimens (recommended and non recommended) and direct 
associated costs. It was also checked patients compliance by analyzing 
pharmacy electronic files.  
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